June 23rd: Biopharma Consortium Breakfast Meeting

Friday, 23 June 2017 8:00 AM - 10:00 AM PST

475 East Grand Ave, Building 42-1D, South San Francisco, CA, 94080, United States

Register Now

Registration

Sale ended

Registration Partial Approval - Free

Enter your discount code

  • Fee
  • Total amount

1. Select Seats

2. Review and Proceed

Friday, 23 June 2017 8:00 AM - 10:00 AM PST

Genentech, 475 East Grand Ave, South San Francisco, CA, 94080, United States.

Precision Medicine, Smarter Patient Segmentation and Post Market Patient Data: New Data Privacy Regulation and Biotech's Bottom Line

 
Speakers:  Kari Kelly
                   Elizabeth Coker
Date/Time:  Friday, June 23rd , 2017, 8:00-10:00 AM, presentation begins at 8:30 sharp
Place:  Genentech, 42-1E in Bldg 42
            475 East Grand Avenue
            South San Francisco 94080
Admission is free, but registration is required by June 20th, 2017
 
Abstract:
This program will address opportunities and consequences of innovation and privacy law as life science companies strive for increased patient interaction.  Innovations such as Artificial Intelligence (AI), Precision Medicine and mobile and always-connected devices, along with the European Union’s new General Data Protection Regulation (GDPR) will have profound impacts on your business and how you collect, transfer and protect patient’s personal and health data. Implementing these innovations can create new opportunities for smarter patient segmentation, interactions and post-market data gathering.  However, without the proper compliance and data strategies in place, they can also put your company at risk for significant fines (up to 4% of a company’s global turnover).  

Attendees will learn how this technological era creates both opportunities and new legal consequences unique to life sciences businesses.  Attendees will leave with a list of best practices for reducing risk and maximizing the commercial and scientific impact associated with genetic, health and other sensitive personal data given today’s evolving regulatory environment.
 
Speaker Bios:
Kari Kelly 
Kari Kelly is a co-founder of Centric Legal and often serves as special privacy counsel.  She is an experienced tech attorney focused on guiding both domestic and international biotech, HealthTech, software, and mobile app companies as they leverage their business data and intellectual property.  Her skills uniquely qualify her to help companies navigate the evolving regulatory environment surrounding data while making their data more useful and valuable.
  
Early on, Kari was an associate at Mayer Brown in Palo Alto, California where she worked with biotech and global pharma companies on intellectual property and licensing matters. She began her career as a Foreign Associate in a premier corporate and intellectual property law firm in Cologne, Germany after her fellowship in German and EU business and intellectual property law with the German Academic Exchange Service (DAAD).  Previously, as in-house counsel for IBM’s Software Group in San Jose, California, Kari worked on cutting edge legal issues at the intersection of the law and technology.  

Kari regularly advises on data licensing, security, privacy and negotiates strategic customer and channel partner arrangements and licensing deals in various tech verticals. 
 
Elizabeth (Liz) Coker
Ms. Coker is a 30-year veteran of digital health, high-tech marketing, sales, operations, and management who is passionate about the practical use of technology to solve real world problems.  She has deep knowledge in the areas of privacy, health-tech trends, go-to-market strategy, and the mobile Web. As co-founder and COO of 5o9, Inc. (dba 3PHealth), she co-invented the patented Contextual Data Communication Platform, whose privacy technology is currently embedded in over 1.5 billion browsers.  At 3PHealth she is working to combine personalization and privacy technologies to simplify and unify digital care delivery and remove the barriers to effective patient-provider collaboration via their Choice® platform.  She is working to build a digital health ecosystem that benefits all healthcare stakeholders through connected digital conversations that fuel the data economy.  She works daily to help organizations identify the opportunities associated with the respectful use of PII, PHI and contextual data to achieve business and health objectives. 

Prior to 5o9, Ms. Coker spent eight years helping early stage businesses develop and execute their go-to-market strategies in her roles as President of Aspenwood Consulting, and Vice President of Marketing and Consulting Services for Tactical Marketing Ventures, including serving as the COO of an otolaryngology and hearing content and referral Web service.  Her early career was based in distribution and high-tech manufacturing where she profitably led a $250 million products division of Access Graphics, Ms. Coker successfully brought to market and managed the best-selling product for Hewlett-Packard’s CMS division, and served in national account sales, operations, and marketing roles during her 10 years with Merisel, where she launched hundreds of products and companies into the channel, including, Intuit, Toshiba, Lotus, Compaq and Microsoft. 
Ms. Coker currently serves as the co-chair of the Prime Health Inclusivity working group, is a CU Professional Mentor, is participating in the CO OeHI Health IT Roadmap development process, and on the Board of the Coolest Women We Know in Technology.
  
*Note: ID required for check-in on event day 

Biopharma Consortium

BioPharma Consortium engages, serves and partners with biotech, pharma, medical device, academia, research institutes and special interest or service groups within the life science industry to provide access to a broad and deep network of professionals and career opportunities fueled by leading edge science, medicine and business.

Contact the Organizer View other events

Comments